YAP1 and non-small cell lung carcinoma: A recent study showed that the YAP/TAZ-TEAD transcriptome is up-regulated following acquired resistance to Sotorasib in KRASG12C NSCLC cell lines, and combination therapy with a pan-TEAD inhibitor, GNE-7883, resensitizes the cells to targeted therapy91.